跳至主要内容
临床试验/CTRI/2022/07/044160
CTRI/2022/07/044160尚未招募2 期

RANDOMIZED CLINICAL TRIAL TO ASSESS THE EFFICACY OF ARAGWADHADI TAILA IN COMPARISON WITH BETADINE LIQUID IN THE MANAGEMENT OF DUSHTA VRANA.

DR AMRUTA ARVIND NARKAR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients having sign and symptoms of Dushta Vrana i.e.infected wound.
  • 2.Dushta Vrana size up to 5Ã?5cms (LxB)
  • 3.Patients of either sex will be selected.
  • 4.The patients of age group 19 - 70 years

排除标准

  • 1.Anaemic patient Hb < 10 gm
  • 2.Malnourished patient (as per age, height and weight proportion)
  • 3.Bleeding disorders (increased B.T and C.T)
  • 4.Patient with septicemia
  • 5.The patients suffering from systemic disease such as AIDS, Tuberculosis, Uncontrolled Diabetes mellitus, Hepatitis-B, Malignancy, Vericose ulcer, Deep vein thrombosis, Neurogenic ulcer, Leukemia, etc.
  • 6.Any congenital diseases or abnormalities.

研究者

发起方
DR AMRUTA ARVIND NARKAR

相似试验